drugset / Trial / NCT06145217
An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL®
NaSingle-groupOpen-labelTreatment
Summary
A drug-drug interaction study designed to evaluate the drug-drug interaction between SPRYCEL® 100 mg (US sourced) and Omeprazole in healthy, adult, human subjects
Timeline
- Start
- 2023-08-22
- Primary completion
- 2023-08-22
- Completion
- 2023-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | 40 mg | — |
| Subject | dasatinib anhydrous | Small molecule | 100 mg | — |
Indications
No indication recorded.